Keyphrases
Metabolism
100%
Giant Cell Arteritis
100%
Interleukin-6
100%
Chronic Inflammatory Diseases
100%
Immune Signature
100%
Disease Foci
100%
Tocilizumab
23%
Polymyalgia Rheumatica
15%
Comorbidity
15%
Nave
15%
Glucocorticoid Therapy
15%
Interleukin-6 Signaling
15%
Dutch
7%
Cellular Metabolism
7%
Aging
7%
Population-based Cohort
7%
Population-based
7%
Macrophages
7%
Elderly Patients
7%
Signaling Pathway
7%
Diagnostic Tool
7%
Lipid Metabolism
7%
Medium Size
7%
Negative Association
7%
Blood Vessels
7%
Large-sized
7%
Infiltration
7%
Disease Activity
7%
Adverse Events
7%
Vasculitis
7%
Therapeutic Strategies
7%
Targeted Treatment
7%
Metabolic Profiling
7%
Glucose Metabolism
7%
Prednisone
7%
Most Common Form
7%
CD4+ T Cells
7%
Interleukin-6 Receptor (IL-6R)
7%
Population-based Registry
7%
Metabolic Disturbances
7%
Macrophage Heterogeneity
7%
Metabolic Features
7%
Metabolic Factors
7%
Inflammatory Rheumatic Diseases
7%
Intravascular Imaging
7%
Glucocorticoid Sparing
7%
Medicine and Dentistry
Giant-Cell Arteritis
100%
Inflammatory Disorder
100%
Interleukin 6
100%
Glucocorticoid
38%
Tocilizumab
23%
Macrophage
15%
Polymyalgia Rheumatica
15%
Diagnosis
7%
Biological Marker
7%
Cohort Analysis
7%
Signal Transduction
7%
Targeted Therapy
7%
Water-Electrolyte Imbalance
7%
Prevalence
7%
Elderly Patient
7%
Vasculitis
7%
Lipid Metabolism
7%
Cell Metabolism
7%
Adverse Event
7%
Interleukin 6 Receptor
7%
Artery
7%
Glucose Metabolism
7%
Disease Activity
7%
Prednisone
7%
Rheumatic Disease
7%
T-Helper Cell
7%
Immunology and Microbiology
Inflammatory Disorder
100%
Giant Cell Arteritis
100%
Interleukin 6
100%
Glucocorticoid
38%
Tocilizumab
23%
Macrophage
15%
Comorbidity
15%
Rheumatic Polymyalgia
15%
Vasculitis
7%
Prevalence
7%
Blood Vessels
7%
T-Helper Cell
7%
Lipid Metabolism
7%
Signal Transduction
7%
Cell Metabolism
7%
Glucose Metabolism
7%
Prednisone
7%
Artery
7%
Rheumatic Disease
7%
Interleukin-6 Receptor
7%